Novoron Bioscience Alternatives & Competitors
12 companies similar to Novoron Bioscience — Pioneering lipoprotein-receptor drug development to repair damage and degenerati...
KeifeRx
KeifeRx is a biopharmaceutical company finding disease-modifying treatments for neurodegen...
Mclean, United States
Tendo - For people, not symptoms
Grasp life with the support of our Tendo Technology - "The first exoskeleton that makes se...
Lund, Sweden
Ipsen
Engineers and develops bacterial-based protein therapeutics for the treatment of neurologi...
Paris, France
Point Pressure
Developing the next big leap in spasticity treatments.
Sant Cugat Del Valles, Sp...
Track all Novoron Bioscience competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Lundbeck
Advancing brain health. Transforming lives.
Valby, Denmark
The Physicians Spine & Rehabilitation Specialists
Diagnose. Treat. Rehabilitate.
Sandy Springs, United Sta...
ProJenX
ProJenX is a clinical-stage biotech developing novel, brain-penetrant MAP4K inhibitors for...
New York, United States
Envisagenics
Artificial Intelligence, High Performance Computing, and RNA sequencing data to find cures...
New York, United States
ROME Therapeutics
Harnessing the power of the repeatome to develop a new class of therapies for cancer and a...
Boston, United States
Monument Therapeutics
Bringing Precision Medicine to Neuroscience Drug Development
Macclesfield, United King...
NOVADIP Biosciences S.A.
Novadip is transforming the lives of patients using its unique 3M³ tissue regeneration tec...
Belgium
Kyverna Therapeutics
Harnessing the power of cell therapy in autoimmune disease.
Emeryville, United States
About Novoron Bioscience
Pioneering lipoprotein-receptor drug development to repair damage and degeneration to the brain, spinal cord and beyond.
Development of innovative therapies, Maximized therapeutic benefit exploration, Discovery and development of new drug modalities
Patients with brain and spinal cord injuries, Individuals experiencing neurodegeneration, Healthcare providers and researchers in neurology
Lipoprotein-receptor Drug Development, Neurological Condition Treatment, Central Nervous System Therapeutics, Multiple Sclerosis Research, Spinal Cord Injury Treatment, Alzheimer's Disease Therapy, Neuronal Regeneration, Remyelination Techniques, Orphan Drug Development, Demyelinating Conditions, Tauopathy Solutions, Neuroscience Innovation, CNS Pathologies
B2B, B2D
Licensing, Product Sales, Service Fee
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Novoron Bioscience and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Novoron Bioscience on 11 Mar 2026. The 12 companies listed here were last checked between 12 Jun 2025 and 11 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.